VANGUARD GROUP INC - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 41 filers reported holding TRANSPHORM INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$3,251,949
-30.2%
1,464,842
+6.9%
0.00%
Q2 2023$4,660,679
-12.7%
1,370,788
+2.5%
0.00%
Q1 2023$5,336,063
-25.7%
1,337,359
+1.2%
0.00%
Q4 2022$7,185,484
+7.0%
1,320,861
-1.1%
0.00%
Q3 2022$6,715,000
+26.1%
1,335,015
-4.5%
0.00%
Q2 2022$5,325,0001,397,5190.00%
Other shareholders
TRANSPHORM INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,609,346$14,401,2915.31%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$90,477,1602.72%
Worth Venture Partners, LLC 884,802$3,530,3601.72%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 253,084$1,009,8051.18%
Black Maple Capital Management LP 43,161$172,2120.16%
Polar Asset Management Partners Inc. 709,700$2,831,7030.04%
Soros Fund Management 639,820$2,552,8820.04%
AMERIPRISE FINANCIAL INC 3,929,048$15,676,9010.01%
Stratos Wealth Partners, LTD. 25,640$102,3040.00%
FMR LLC 1,584$6,3200.00%
View complete list of TRANSPHORM INC shareholders